Cargando…
The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study
End-of-life advance care planning (ACP) has become increasingly important in home care setting. In facilitating ACP discussion in home care setting, accurate understanding of patients’ survival would be beneficial because it would facilitate healthcare professionals to individualize ACP discussion....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545356/ https://www.ncbi.nlm.nih.gov/pubmed/34559116 http://dx.doi.org/10.1097/MD.0000000000027225 |
_version_ | 1785114654271340544 |
---|---|
author | Kosaka, Makoto Miyatake, Hirotomo Kotera, Yasuhiro Masunaga, Hidehisa Arita, Satoshi Tsunetoshi, Chie Nishikawa, Yoshitaka Ozaki, Akihiko Beniya, Hiroyuki |
author_facet | Kosaka, Makoto Miyatake, Hirotomo Kotera, Yasuhiro Masunaga, Hidehisa Arita, Satoshi Tsunetoshi, Chie Nishikawa, Yoshitaka Ozaki, Akihiko Beniya, Hiroyuki |
author_sort | Kosaka, Makoto |
collection | PubMed |
description | End-of-life advance care planning (ACP) has become increasingly important in home care setting. In facilitating ACP discussion in home care setting, accurate understanding of patients’ survival would be beneficial because it would facilitate healthcare professionals to individualize ACP discussion. However, little is known about survival outcome of home care patients. This study aimed to clarify the outcome of patients and identify factors to better predict the survival outcome of home care patients with the focus on patients’ primary diseases. We conducted a retrospective analysis using data from 277 patients managed at a home care clinic in Japan and first treated in 2017 or 2018. Data regarding sociodemographic and clinical characteristics, and clinical outcome on December 31, 2019 were extracted. Using Kaplan–Meier product-limit method, we estimated the overall 30 days, 90 days, 1 year, and 3 year survival probabilities among the entire patients and their differences according to their primary disease. We also evaluated whether outcomes differed based on the primary disease or other factors using the hazard ratio and Cox proportional hazards regression. The overall survival probability was 82.5% at 30 days, 67.8% at 90 days, 52.7% at 1 year, and 39.1% at 3 years. The survival rates at 30 days, 90 days, 1 year, and 3 years were 64.6%, 33.4%, 9.5%, and 4.1% among cancer patients; 91.9%, 86.4%, 78.1%, and 47.0% among dementia patients; and 91.9%, 86.4%, 78.1%, and 47.0% among patients with other nervous and cerebrovascular diseases, respectively. Cox proportional hazard regression clarified that cancer patients (hazard ratio 6.53 [95% CI 4.16–10.28]) and older adults (hazard ratio 1.01 [95% CI 1.00–1.02]) were significantly more likely to die than dementia patients and young patients, respectively. Primary disease had a significant influence on the prediction of survival time and could be a useful indicator to individualize ACP in home care setting. |
format | Online Article Text |
id | pubmed-10545356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-105453562023-10-03 The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study Kosaka, Makoto Miyatake, Hirotomo Kotera, Yasuhiro Masunaga, Hidehisa Arita, Satoshi Tsunetoshi, Chie Nishikawa, Yoshitaka Ozaki, Akihiko Beniya, Hiroyuki Medicine (Baltimore) 6100 End-of-life advance care planning (ACP) has become increasingly important in home care setting. In facilitating ACP discussion in home care setting, accurate understanding of patients’ survival would be beneficial because it would facilitate healthcare professionals to individualize ACP discussion. However, little is known about survival outcome of home care patients. This study aimed to clarify the outcome of patients and identify factors to better predict the survival outcome of home care patients with the focus on patients’ primary diseases. We conducted a retrospective analysis using data from 277 patients managed at a home care clinic in Japan and first treated in 2017 or 2018. Data regarding sociodemographic and clinical characteristics, and clinical outcome on December 31, 2019 were extracted. Using Kaplan–Meier product-limit method, we estimated the overall 30 days, 90 days, 1 year, and 3 year survival probabilities among the entire patients and their differences according to their primary disease. We also evaluated whether outcomes differed based on the primary disease or other factors using the hazard ratio and Cox proportional hazards regression. The overall survival probability was 82.5% at 30 days, 67.8% at 90 days, 52.7% at 1 year, and 39.1% at 3 years. The survival rates at 30 days, 90 days, 1 year, and 3 years were 64.6%, 33.4%, 9.5%, and 4.1% among cancer patients; 91.9%, 86.4%, 78.1%, and 47.0% among dementia patients; and 91.9%, 86.4%, 78.1%, and 47.0% among patients with other nervous and cerebrovascular diseases, respectively. Cox proportional hazard regression clarified that cancer patients (hazard ratio 6.53 [95% CI 4.16–10.28]) and older adults (hazard ratio 1.01 [95% CI 1.00–1.02]) were significantly more likely to die than dementia patients and young patients, respectively. Primary disease had a significant influence on the prediction of survival time and could be a useful indicator to individualize ACP in home care setting. Lippincott Williams & Wilkins 2021-09-24 /pmc/articles/PMC10545356/ /pubmed/34559116 http://dx.doi.org/10.1097/MD.0000000000027225 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | 6100 Kosaka, Makoto Miyatake, Hirotomo Kotera, Yasuhiro Masunaga, Hidehisa Arita, Satoshi Tsunetoshi, Chie Nishikawa, Yoshitaka Ozaki, Akihiko Beniya, Hiroyuki The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study |
title | The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study |
title_full | The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study |
title_fullStr | The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study |
title_full_unstemmed | The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study |
title_short | The survival time of end-of-life home care patients in Fukui prefecture, Japan: A retrospective observational study |
title_sort | survival time of end-of-life home care patients in fukui prefecture, japan: a retrospective observational study |
topic | 6100 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545356/ https://www.ncbi.nlm.nih.gov/pubmed/34559116 http://dx.doi.org/10.1097/MD.0000000000027225 |
work_keys_str_mv | AT kosakamakoto thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT miyatakehirotomo thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT koterayasuhiro thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT masunagahidehisa thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT aritasatoshi thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT tsunetoshichie thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT nishikawayoshitaka thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT ozakiakihiko thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT beniyahiroyuki thesurvivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT kosakamakoto survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT miyatakehirotomo survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT koterayasuhiro survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT masunagahidehisa survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT aritasatoshi survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT tsunetoshichie survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT nishikawayoshitaka survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT ozakiakihiko survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy AT beniyahiroyuki survivaltimeofendoflifehomecarepatientsinfukuiprefecturejapanaretrospectiveobservationalstudy |